摘要
背景:目前研究表明吸烟和饮酒与痴呆的发生率并不一致。目的:我们对吸烟和饮酒与患有痴呆的风险性之间关系进行了评估,其中对阿尔茨海默症(AD)和血管性痴呆症(VaD)病人进行了7年随访。实验设计:根据他们的吸烟和饮酒情况,我们对2004-2011年的2959位老年人痴呆症的发生率进行了回顾性分析。样本:来自重庆市3个区的6个社区。参与者:对3170位男性随访了7年。检测方法:为了评估吸烟和饮酒与患有痴呆风险之间的联系,我们建立了Cox比例风险模型。结果:通过7年随访,我们发现目前吸烟的和每天吸烟的AD和AaD的发生几率分别高于从不吸烟的人群(P<0.01)。在平衡了年龄和其它混杂因素后,目前吸烟的与增加患AD (HR= 2.14, 95% CI 1.20-4.46) 和VaD (HR= 3.42, 95% CI 1.18-4.51) 的风险性相联系;与此同时,每日饮酒与增加患AD (HR= 2.25, 95% CI 1.43-3.97) 和VaD (HR= 3.42, 95% CI 1.18-4.51)的风险性相关。另外,同时吸烟和饮酒的人比从不吸烟和饮酒的人有明显高的患有AD (HR= 3.03, 95% CI 1.65-4.19) 和VaD (HR= 3.96, 95% CI 1.64-4.71) 的风险性;而且,与目前吸烟和每日饮酒的相比,同时吸烟和饮酒的患AD和VaD的风险性更高。结论:发现目前吸烟和每日饮酒的老年人与痴呆有明显的关联性。
关键词: 饮酒,阿尔茨海默病,吸烟,血管性痴呆
Current Alzheimer Research
Title:Association of Smoking and Alcohol Drinking with Dementia Risk Among Elderly Men in China
Volume: 11 Issue: 9
Author(s): Shiming Zhou, Rui Zhou, Tingting Zhong, Rui Li, Jun Tan and Huadong Zhou
Affiliation:
关键词: 饮酒,阿尔茨海默病,吸烟,血管性痴呆
摘要: Background: Previous studies relating smoking and alcohol drinking with the incidence of dementia have been inconsistent. Objectives: We assessed whether smoking and alcohol drinking was associated with the risk of dementia, including Alzheimer disease (AD) and vascular dementia (VaD) after seven years of follow-up. Design: We prospectively analysed the incidence of dementia from 2004 to 2011 among 2959 elderly men, according to their smoking and alcohol drinking status. Setting: six neighbourhoods from three districts mentioned in Chongqing city. Participants: A total of 3170 men were followed up annually for 7 years. Measurements: Cox proportional hazards models were established to evaluate the association between smoking, alcohol drinking and the risk of dementia. Results: The incidences of AD and VaD were higher respectively in current smoking than never smoking, daily drinking than never drinking over 7 years of follow-up (p<0.01). After adjusting for age and other potential confounders, current smoking was associated with increased risk of AD (HR= 2.14, 95% CI 1.20-4.46) and VaD (HR= 3.28, 95% CI 1.14-4.52), meanwhile, daily drinking was related to increased risk of AD (HR= 2.25, 95% CI 1.43-3.97) and VaD (HR= 3.42, 95% CI 1.18-4.51). In addition, co-smoking and drinking were related to with a significantly higher risk of AD and VaD than non-smoking and drinking (HR= 3.03, 95% CI 1.65-4.19) and VaD (HR= 3.96, 95% CI 1.64-4.71). Moreover, co-smoking and drinking had higher risk of AD and VaD compared with current smoking and daily drinking. Conclusions: Current smoking and daily drinking were found to be significantly associated with dementia in elderly men.
Export Options
About this article
Cite this article as:
Zhou Shiming, Zhou Rui, Zhong Tingting, Li Rui, Tan Jun and Zhou Huadong, Association of Smoking and Alcohol Drinking with Dementia Risk Among Elderly Men in China, Current Alzheimer Research 2014; 11 (9) . https://dx.doi.org/10.2174/1567205011666141001123356
DOI https://dx.doi.org/10.2174/1567205011666141001123356 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
PCSK9 and LDLR The Yin-Yang in the Cellular Uptake of Cholesterol
Current Hypertension Reviews Pitavastatin and 4-Hydroxy-3-Methoxyacetophenone (HMAP) Reduce Cognitive Dysfunction in Vascular Dementia During Experimental Diabetes
Current Neurovascular Research The Use of Stem Cells in Regenerative Medicine for Parkinson’s and Huntington’s Diseases
Current Medicinal Chemistry Biotechnological Approaches for the Treatment of Inflammatory Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Gene-Gene and Gene-Environment Interaction on the Risk of Parkinson’s Disease
Current Aging Science On the Relationship Between the Light/Dark Cycle, Melatonin and Oxidative Stress
Current Pharmaceutical Design Automatic Detection of Cognitive Impairments through Acoustic Analysis of Speech
Current Alzheimer Research Cervical Cancer Diagnosis: Insights into Biochemical Biomarkers and Imaging Techniques
Combinatorial Chemistry & High Throughput Screening An Overview of Notch Signaling in Adult Tissue Renewal and Maintenance
Current Alzheimer Research Development of a Novel and Robust Pharmacological Model of Okadaic Acid-induced Alzheimer’s Disease in Zebrafish
CNS & Neurological Disorders - Drug Targets Protein Folding and Misfolding, Endoplasmic Reticulum Stress in Neurodegenerative Diseases: in Trace of Novel Drug Targets
Current Protein & Peptide Science Differential Cued-Stroop Performance in Cognitively Asymptomatic Older Adults with Biomarker-Identified Risk for Alzheimer’s Disease: A Pilot Study
Current Alzheimer Research Synthesis and Evaluation of Substituted 4-methyl-2-oxo-2H-chromen-7-yl Phenyl Carbamates as Potent Acetylcholinesterase Inhibitors and Anti- Amnestic Agents
Medicinal Chemistry Tyrosine Hydroxylase Gene: Another Piece of the Genetic Puzzle of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Patent Selections
Recent Patents on Biomarkers An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research
Current Drug Abuse Reviews The Role of Inflammatory Response in Stroke Associated Programmed Cell Death
Current Neuropharmacology Possible Pathomechanisms Responsible for Injury to the Central Nervous System in the Settings of Chronic Cerebrospinal Venous Insufficiency
Reviews on Recent Clinical Trials TRPM6 and TRPM7: A Mul-TRP-PLIK-Cation of Channel Functions
Current Pharmaceutical Biotechnology The Gastrin-Releasing Peptide Receptor as a Therapeutic Target in Central Nervous System Disorders
Recent Patents on CNS Drug Discovery (Discontinued)